Key facts
- This page summarizes Andrew J. Murphy's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Dec 2025, 16:32.
Andrew J. Murphy - 09 Dec 2025 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)
- Reporting relationship
- EVP Research
- Issuer ticker
- REGN
- Reported as of
- 09 Dec 2025
- Net transaction value
- -$2,966,686
- SEC form
- 4
- Accepted by SEC
- 11 Dec 2025, 16:32:45 UTC
- Prior SEC filing
- 09 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Murphy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Murphy filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 11 Dec 2025.
Change
- Previous filing in this sequence was filed on 09 Dec 2025.
- Current net transaction value: -$2,966,686.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001796226
Primary reporting owner
MURPHY ANDREW J
- Relationship
- EVP Research
- Address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN
- Signature
- /s/ Andrew Murphy
- Signature date
- 11 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
REGN
transaction
Common Stock
Tax liability
- Transaction value
- $2,966,686
- Shares
- -4,229
- Change %
- -8.1%
- Price
- $701.51
- Shares after
- 47,833
- Date
- 09 Dec 2025
- Ownership
- Direct
REGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,375
- Date
- 09 Dec 2025
- Ownership
- By 401(k) Plan
* marks a reported price that did not pass the local price check.